CVI Investments, Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:21 pm Unchanged |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 3.600% |
0 (Unchanged) |
Filing |
| 2021-06-14 1:14 pm Purchase |
2021-06-03 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 5.000% |
40,000 (New Position) |
Filing |